Acyclovir
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
54348-627 -
Package NDC
54348-627-10 -
Package NDC
54348-627-15 -
Package NDC
54348-627-20 -
Package NDC
54348-627-21 -
Package NDC
54348-627-25 -
Package NDC
54348-627-30 -
Package NDC
54348-627-60 -
Application number
ANDA203834 -
SPL ID
ea937906-dba1-207f-e053-2a95a90a111e -
SPL set ID
8fb01f23-e2bd-6850-e053-2995a90a7cc5 -
UNII
X4HES1O11F -
RxCUI
197311
What the source publishes
- Labeler
- PharmPak, Inc.
- Active ingredients
- Acyclovir
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Acyclovir",
"splId": "ea937906-dba1-207f-e053-2a95a90a111e",
"labels": [
{
"setId": "8fb01f23-e2bd-6850-e053-2995a90a7cc5",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8fb01f23-e2bd-6850-e053-2995a90a7cc5",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8fb01f23-e2bd-6850-e053-2995a90a7cc5"
}
],
"routes": [
"ORAL"
],
"labeler": "PharmPak, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 BOTTLE in 1 BOX (54348-627-10) / 10 TABLET in 1 BOTTLE",
"package_ndc": "54348-627-10",
"identifierStatus": "well-formed",
"marketing_start_date": "20190808"
},
{
"sample": false,
"description": "1 BOTTLE in 1 BOX (54348-627-15) / 15 TABLET in 1 BOTTLE",
"package_ndc": "54348-627-15",
"identifierStatus": "well-formed",
"marketing_start_date": "20190808"
},
{
"sample": false,
"description": "1 BOTTLE in 1 BOX (54348-627-20) / 20 TABLET in 1 BOTTLE",
"package_ndc": "54348-627-20",
"identifierStatus": "well-formed",
"marketing_start_date": "20190808"
},
{
"sample": false,
"description": "1 BOTTLE in 1 BOX (54348-627-21) / 21 TABLET in 1 BOTTLE",
"package_ndc": "54348-627-21",
"identifierStatus": "well-formed",
"marketing_start_date": "20190808"
},
{
"sample": false,
"description": "1 BOTTLE in 1 BOX (54348-627-25) / 25 TABLET in 1 BOTTLE",
"package_ndc": "54348-627-25",
"identifierStatus": "well-formed",
"marketing_start_date": "20190808"
},
{
"sample": false,
"description": "1 BOTTLE in 1 BOX (54348-627-30) / 30 TABLET in 1 BOTTLE",
"package_ndc": "54348-627-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20190808"
},
{
"sample": false,
"description": "1 BOTTLE in 1 BOX (54348-627-60) / 60 TABLET in 1 BOTTLE",
"package_ndc": "54348-627-60",
"identifierStatus": "well-formed",
"marketing_start_date": "20190808"
}
],
"productId": "54348-627_ea937906-dba1-207f-e053-2a95a90a111e",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "54348-627",
"deaSchedule": null,
"genericName": "Acyclovir",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ACYCLOVIR",
"strength": "400 mg/1"
}
],
"applicationNumber": "ANDA203834",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20131129",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000020060",
"N0000180187",
"N0000180188",
"N0000175468",
"N0000175459"
],
"unii": [
"X4HES1O11F"
],
"rxcui": [
"197311"
],
"spl_set_id": [
"8fb01f23-e2bd-6850-e053-2995a90a7cc5"
],
"pharm_class_epc": [
"Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]",
"Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]",
"Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"
],
"pharm_class_moa": [
"DNA Polymerase Inhibitors [MoA]"
],
"manufacturer_name": [
"PharmPak, Inc."
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:54348-627_ea937906-dba1-207f-e053-2a95a90a111e"